TCDD deregulates contact inhibition in rat liver oval cells via Ah receptor, JunD and cyclin A

Oncogene

Volumn 27, Issue 15, 2008, Pages 2198-2207

  Weiss, C ^a,b   Faust, D ^a   Schreck, I ^b   Ruff, A ^a   Farwerck, T ^a   Melenberg, A ^a   Schneider, S ^b   Oesch Bartlomowicz, B ^a   Zatloukalova J ^c   Vondracek J ^c   Oesch, F ^a   Dietrich, C ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^c INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

Aryl hydrocarbon receptor; Cell cycle control; Contact inhibition; Cyclin A; JunD; Liver oval cells

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CYCLIN A; TRANSCRIPTION FACTOR JUND;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CONTACT INHIBITION; LIVER CARCINOGENESIS; LIVER CELL CULTURE; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; PROTO ONCOGENE; RAT; TRANSCRIPTION INITIATION; UPREGULATION;

ADULT STEM CELLS; ANIMALS; CELLS, CULTURED; CONTACT INHIBITION; CYCLIN A; LIVER; MODELS, BIOLOGICAL; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RECEPTORS, ARYL HYDROCARBON; RNA, SMALL INTERFERING; TETRACHLORODIBENZODIOXIN;

RATTUS;

EID: 41649093550     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210859     Document Type: Article

References (50)

1. Abercrombie M. (1979). Contact inhibition and malignancy. Nature 281: 259-262.
2. Andersson P, McGuire J, Rubio C, Gradin K, Whitelaw ML, Pettersson S et al. (2002). A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors. Proc Natl Acad Sci USA 99: 9990-9995.
3. Andrews NC, Faller DV. (1991). A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19: 2499.
4. Bock KW, Kohle C. (2005). Ah receptor- and TCDD-mediated liver tumor promotion: clonal selection and expansion of cells evading growth arrest and apoptosis. Biochem Pharmacol 69: 1403-1408.
5. Casalino L, Bakiri L, Talotta F, Weitzman JB, Fusco A, Yaniv M et al. (2007). Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription. EMBO J 26: 1878-1890.
6. Chang C-H, Puga A. (1998). Constitutive activation of the aromatic hydrocarbon receptor. Mol Cell Biol 18: 525-535.
7. Chramostova K, Vondracek J, Sindlerova L, Vojtesek B, Kozubik A, Machala M. (2004). Polycyclic aromatic hydrocarbons modulate cell proliferation in rat hepatic epithelial stem-like WB-F344 cells. Toxicol Appl Pharmacol 196: 136-148.
8. Coleman W, McCullough K, Esch G, Faris R, Hixson S, Smith G et al. (1997). Evaluation of the differentiation potential of WB-F344 rat liver epithelial stem-like cells in vivo. Differentiation to hepatocytes after transplantation into dipeptidylpeptidase-IV-deficient rat liver. Am J Pathol 151: 353-359.
9. De Groot RP, Karperien M, Pals C, Kruijer W. (1991). Characterization of the mouse junD promoter-high basal level activity due to an octamer motif. EMBO J 10: 2523-2532.
10. Dietrich C, Bartsch T, Schanz F, Oesch F, Wieser R. (1996). p53-dependent cell cycle arrest induced by N-acetyl-L-leucinyl-L- leucinyl-L-norleucinal in platelet-derived growth factor-stimulated human fibroblasts. Proc Natl Acad Sci USA 93: 10815-10819.
11. Dietrich C, Wallenfang K, Oesch F, Wieser F. (1997). Differences in the mechanisms of growth control in contact-inhibited and serum-deprived human fibroblasts. Oncogene 15: 2743-2747.
12. Dietrich C, Faust D, Budt S, Moskwa M, Kunz A, Bock K-W et al. (2002). 2,3,7,8-Tetrachlorodibenzo-p-dioxin-dependent release from contact inhibition in WB-F344 cells: involvement of cyclin A. Toxicol Appl Pharmacol 183: 117-126.
13. Dietrich C, Faust D, Moskwa M, Kunz A, Bock K-W, Oesch F. (2003). TCDD-dependent downregulation of gamma-catenin in rat liver epithelial cells (WB-F344). Int J Cancer 103: 435-439.
14. Dumble ML, Croager EJ, Yeoh GCT, Quail EA. (2002). Generation and characterization of p53 null transformed hepatic progenitor cells: oval cells give rise to hepatocellular carcinoma. Carcinogenesis 23: 435-445.
15. Eagle H, Levine E. (1967). Growth regulatory effects of cellular interaction. Nature 213: 1102-1106.
16. Faust D, Dolado I, Cuadrado A, Oesch F, Weiss C, Nebreda AR et al. (2005). p38alpha MAPK is required for contact inhibition. Oncogene 24: 7941-7945.
17. Fox TR, Best LL, Goldsworthy SM, Mills JJ, Goldsworthy TL. (1993). Gene expression and cell proliferation in rat liver after 2,3,7,8-tetrachlorodibenzo- p-dioxin exposure. Cancer Res 53: 2265-2271.
18. Hailey JR, Walker NJ, Sells DM, Brix AE, Jokinen MP, Nyska A. (2005). Classification of proliferative hepatocellular lesions in Harlan Sprague-awley rats chronically exposed to dioxin-like compounds. Toxicol Pathol 33: 165-174.
19. Hebert C, Cao Q-L, Birnbaum L. (1990). Inhibition of highdensity growth arrest in human squamous carcinoma cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Carcinogenesis 11: 1335-1342.
20. Heit I, Wieser R, Herget T, Faust D, Borchert-Stuhlträger M, Oesch F et al. (2001). Involvement of protein kinase C delta in contactdependent inhibition of growth in human and murine fibroblasts. Oncogene 20: 5143-5154.
21. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA. (1992). Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70: 993-1006.
22. Hoffer A, Chang CY, Puga A. (1996). Dioxin induces transcription of fos and jun genes by Ah receptor-dependent and -independent pathways. Toxicol Appl Pharmacol 141: 238-247.
23. Hushka DR, Greenlee WF. (1995). 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits DNA synthesis in rat primary hepatocytes. Mut Res 333: 89-99.
24. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1997) In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 69, IARC Press: Lyon, France, pp 1-643.
25. Kolluri SK, Weiss C, Koff, Göttlicher M. (1999). p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev 15: 1742-1753.
26. Libbrecht L, Desmet V, van Damme B, Roskams T. (2000). The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. J Hepatol 33: 76-84.
27. Ma Q, Whitlock Jr JP. (1996). The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Mol Cell Biol 16: 8878-8884.
28. Marlowe J, Puga A. (2005). Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J Cell Biochem 96: 1174-184.
29. Mason GG, Witte AM, Whitelaw ML, Antonsson C, McGuire J, Wilhelmsson A et al. (1994). Purification of the DNA binding form of dioxin receptor. Role of the Arnt cofactor in regulation of dioxin receptor. J Biol Chem 269: 4438-4449.
30. Moennikes O, Loeppen S, Buchmann A, Andersson P, Ittrich C, Poellinger L et al. (2004). A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice. Cancer Res 64: 4707-710.
31. Münzel P, Bock-Hennig B, Schieback S, Gschaidmeier H, Beck-Gschaidmeier S, Bock K-W. (1996). Growth modulation of hepatocytes and rat liver epithelial cells (WB-F344) by 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD). Carcinogenesis 17: 197-02.
32. Musti AM, Treier M, Peverali FA, Bohmann D. (1996). Differential regulation of c-Jun and JunD by ubiquitin-dependent protein degradation. Biol Chem 377: 619-24.
33. Nebert D, Dalton TP, Okey AB, Gonzales FJ. (2004). Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 23: 23847-3850.
34. Pitot HC, Goldsworthy T, Campell HA, Poland A. (1980). Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethyl-nitrosamine. Cancer Res 40: 3616-3620.
35. Puga A, Nebert DW, Carrier F. (1992). Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. DNA Cell Biol 11: 269-281.
36. Shafritz DA, Dabeva MD. (2002). Liver stem cells and model systems for liver repopulation. J Hepatol 36: 552-564.
37. Shaulian E, Karin M. (2001). AP-1 in cell proliferation and survival. Oncogene 20: 2390-2400.
38. Shimizu M, Nomura Y, Suzuki H, Ichikawa E, Takeuchi A, Suzuki M et al. (1998). Activation of the rat cyclin A promoter by ATF2 and Jun family members and its suppression by ATF4. Exp Cell Res 239: 93-103.
39. Steinberg P, Steinbrecher R, Radaeva S, Schirmacher P, Dienes HP, Oesch F et al. (1994). Oval cell lines OC/CDE 6 and OC/CDE 22 give rise to cholangio-cellular and undifferentiated carcinomas after transformation. Lab Invest 71: 700-709.
40. Stinchcombe S, Buchmann A, Bock K-W, Schwarz M. (1995). Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumour promotion in rat liver. Carcinogenesis 16: 1271-1275.
41. Tsao M-S, Smith J, Nelson K, Grisham J. (1984). A diploid epithelial cell line from normal adult rat liver with phenotypic properties of 'oval' cells. Exp Cell Res 154: 38-52.
42. Tsao M-S, Grisham J. (1987). Hepatocarcinomas, cholangiocarcinomas, and hepatoblastomas produced by chemically transformed cultured rat liver epithelial cells. A light- and electron-microscopic analysis. Am J Pathol 127: 168-181.
43. Tuomisto J. (2005). Does mechanistic understanding help in risk assessment - the example of dioxins. Toxicol Appl Pharmacol 207: S2-10.
44. Vondracek J, Machala M, Bryja V, Chramostova K, Krcmar P, Dietrich C et al. (2005). Aryl hydrocarbon receptor-activating polychlorinated biphenyls and their hydroxylated metabolites induce cell proliferation in contact-inhibited rat liver epithelial cells. Toxicol Sci 83: 53-3.
45. Weiss C, Kolluri SK, Kiefer F, Göttlicher M. (1996). Complementation of Ah receptor deficiency in hepatoma cells: negative feedback regulation and cell cycle control by the Ah receptor. Exp Cell Res 226: 154-163.
46. Weiss C, Schneider S, Wagner EF, Zhang X, Seto E, Bohmann D. (2003). JNK phosphorylation relieves HDAC3-dependent suppression of the transcriptional activity of c-Jun. EMBO J 22: 3686-3695.
47. Weiss C, Faust D, Dürk H, Kolluri SK, Pelzer A, Schneider S et al. (2005). TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38-MAPK-dependent pathway. Oncogene 24: 4975-983.
48. Weitzman JB, Fiette L, Matsuo K, Yaniv M. (2000). JunD protects cells from p53-dependent senescence and apoptosis. Mol Cell 6: 1109-1119.
49. Wieser R, Faust D, Dietrich C, Oesch F. (1999). p16INK4 mediates contact-inhibition of growth. Oncogene 18: 277-81.
50. Wörner W, Schrenk D. (1996). Influence of liver tumor promoters on apoptosis in rat hepatocytes induced by 2-acetylaminofluorene, ultraviolet light, or transforming growth factor beta 1. Cancer Res 56: 1272-1278.